Mega Lifesciences Public Company Limited (MEGA-R) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.046x

Based on the latest financial reports, Mega Lifesciences Public Company Limited (MEGA-R) has a cash flow conversion efficiency ratio of 0.046x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿461.26 Million ≈ $14.38 Million USD) by net assets (฿9.95 Billion ≈ $310.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Mega Lifesciences Public Company Limited worth for the company's overall valuation and market capitalisation.

Mega Lifesciences Public Company Limited - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Mega Lifesciences Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mega Lifesciences Public Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mega Lifesciences Public Company Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Mega Lifesciences Public Company Limited to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Woori Technology Inc KQ:032820	-0.028x
Shenzhen Tianyuan Dic Info Tech SHE:300047	0.161x
Foshan Golden Milky Way Intelligent Equipment Co Ltd SHE:300619	0.170x
Nufarm Ltd AU:NUF	-0.169x
XiAn Tian He Defense Technology Co Ltd SHE:300397	-0.012x
AXISCADES Technologies Limited NSE:AXISCADES	0.019x
Shanghai Chuangli Group Co Ltd SHG:603012	0.010x
Zhejiang Meili High Technology Co Ltd SHE:300611	0.062x

Annual Cash Flow Conversion Efficiency for Mega Lifesciences Public Company Limited (2011–2024)

The table below shows the annual cash flow conversion efficiency of Mega Lifesciences Public Company Limited from 2011 to 2024. View MEGA-R share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	฿9.88 Billion ≈ $307.85 Million	฿2.40 Billion ≈ $74.85 Million	0.243x	+17.40%
2023-12-31	฿9.30 Billion ≈ $289.94 Million	฿1.93 Billion ≈ $60.05 Million	0.207x	-8.96%
2022-12-31	฿8.78 Billion ≈ $273.56 Million	฿2.00 Billion ≈ $62.23 Million	0.227x	-33.05%
2021-12-31	฿8.03 Billion ≈ $250.14 Million	฿2.73 Billion ≈ $84.99 Million	0.340x	+45.53%
2020-12-31	฿6.98 Billion ≈ $217.53 Million	฿1.63 Billion ≈ $50.79 Million	0.233x	-3.57%
2019-12-31	฿6.18 Billion ≈ $192.47 Million	฿1.50 Billion ≈ $46.60 Million	0.242x	+50.75%
2018-12-31	฿5.72 Billion ≈ $178.42 Million	฿919.36 Million ≈ $28.66 Million	0.161x	-9.14%
2017-12-31	฿5.24 Billion ≈ $163.46 Million	฿927.00 Million ≈ $28.89 Million	0.177x	-34.37%
2016-12-31	฿4.68 Billion ≈ $145.87 Million	฿1.26 Billion ≈ $39.29 Million	0.269x	+91.67%
2015-12-31	฿4.33 Billion ≈ $135.11 Million	฿609.12 Million ≈ $18.99 Million	0.141x	-8.98%
2014-12-31	฿3.98 Billion ≈ $124.00 Million	฿614.22 Million ≈ $19.14 Million	0.154x	+22.40%
2013-12-31	฿3.69 Billion ≈ $115.09 Million	฿465.77 Million ≈ $14.52 Million	0.126x	-40.02%
2012-12-31	฿1.63 Billion ≈ $50.69 Million	฿342.02 Million ≈ $10.66 Million	0.210x	+3.97%
2011-12-31	฿1.32 Billion ≈ $41.09 Million	฿266.67 Million ≈ $8.31 Million	0.202x	--

About Mega Lifesciences Public Company Limited

BK:MEGA-R Thailand Drug Manufacturers - Specialty & Generic

Market Cap

$869.61 Million

฿27.90 Billion THB

Market Cap Rank

#9646 Global

#91 in Thailand

Share Price

฿32.00

Change (1 day)

+0.00%

52-Week Range

฿32.00 - ฿32.00

All Time High

฿52.19